Nuclear factor κB subunits induce epithelial cell growth arrest

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4085-4092

  Seitz, C S ^a   Deng, H ^a   Hinata, K ^a   Lin, Q ^a   Khavari, P A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P21; PROTEIN SUBUNIT; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; GROWTH INHIBITOR;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; ENZYME INDUCTION; EPIDERMIS; EPIDERMIS HYPERPLASIA; EPITHELIUM CELL; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIVISION; CYTOLOGY; GENETICS; HYPERPLASIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

ANIMALS; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; GROWTH INHIBITORS; HUMANS; HYPERPLASIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; SKIN;

EID: 0033624673     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. The serial cultivation of human diploid cell strains
2. Replicative senescence: The human fibroblast comes of age
3. Replicative senescence: An old lives' tale?
4. Integrators of epidermal growth and differentiation: Distinct functions for β 1 and β 4 integrins
5. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
6. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts
7. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
8. Overcoming cellular senescence in human cancer pathogenesis
9. Involvement of RB-1, p53, p16INK4 and telomerase in immortalisation of human cells
10. Increased p53 protein associated with aging in human diploid fibroblasts
11. Increased activity of p53 in senescing fibroblasts
12. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
13. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts
14. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
15. Nonmelanoma skin cancer in the United States: Incidence
16. Altered profile of transcription factor-binding activities in senescent human fibroblasts
17. NF-κB: Ten years after
18. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
19. The NF-κB and IκB proteins: New discoveries and insights
20. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
21. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
22. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism
23. Identification and characterization of an Iκb kinase
24. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
25. IκB kinase-κ. NF-κB activation and complex formation with IκB kinase-α and NIK
26. TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105
27. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB
28. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling
29. Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes
30. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes rastumor progression
31. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription
32. Corrective gene transfer in the human skin disorder lamellar ichthyosis
33. A biomarker that identifies senescent human cells in culture and in aging skin in vivo
34. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
35. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
36. High efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes
37. 1 checkpoint control
38. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus
39. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
40. Suppression of TNF-α-induced apoptosis by NF-κB
41. Inhibition of transcription factors belonging to the rel/NF-κB family by a transdominant negative mutant
42. Induction of basal cell carcinoma features in transgenic human skin expressing sonic hedgehog
43. Regulation of proliferation-specific and differentiation-specific genes during senescence of human epidermal keratinocyte and mammary epithelial cells
44. Progressive loss of the proliferative response of senescing WI-38 cells to platelet-derived growth factor, epidermal growth factor, insulin, transferrin, and dexamethasone
45. In vitro assessment of keratinocyte aging
46. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator
47. Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis
48. Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb
49. 1 transition in mouse fibroblasts
50. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression
51. Disruption of IκBα regulation by antisense RNA expression leads to malignant transformation
52. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
53. Re: 'Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-κ B' (letter)
54. Limb and skin abnormalities in mice lacking IKKα
55. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
56. 1/S phase transition
57. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
58. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
59. p53-Independent expression of p21Cip1 in muscle and other terminally differentiating cells
60. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation
61. Coexpression of p21Waf1/Cip1 and p53 in sun-exposed normal epidermis, but not in neoplastic epidermis
62. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues
63. IKK1-deficient mice exhibit abnormal development of skin and skeleton
64. The beginning of the end: IκB kinase (IKK) and NF-κB activation
65. Molecular basis of sun-induced premature skin ageing and retinoid antagonism
66. WAF1, a potential mediator of p53 tumor suppression
67. p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
68. p21-Negative regulator of the cell cycle
69. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
70. Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF
71. Glucocorticoid receptormediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms
72. 1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta
73. 1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors
74. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1
75. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter
76. CCAAT/enhancer-binding protein α (C/EBP α) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SD1-1) protein
77. Influence of 3' half-site sequence of NF-kappa B motifs on the binding of lipopolysaccharide-activatable macrophage NF-κB proteins